Position in NVS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$56,262
+$6,771 QoQ
Shares Held
359
+10.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,422
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aventura Private Wealth, LLC holds $10,329,222 across 15 Drug Manufacturers - General names. NVS ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,078 | $4,891,275 | |
| 2 | ABBV |
AbbVie Inc.
|
9,370 | $2,357,866 | |
| 3 | JNJ |
Johnson & Johnson
|
4,210 | $1,069,213 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
9,911 | $571,071 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,130 | $530,705 | |
| 6 | PFE |
Pfizer Inc
|
14,517 | $349,569 | |
| 7 | AMGN |
Amgen Inc
|
347 | $125,655 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
945 | $119,391 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,262 | 359 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $49,491 | 324 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $44,669 | 324 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $41,549 | 324 | Shares | Sole | 2026-01-07 | |
| 2025-06-30 | $39,207 | 324 | Shares | Sole | 2026-01-07 | |
| 2025-03-31 | $36,119 | 324 | Shares | Sole | 2026-01-07 | |
| 2024-12-31 | $31,528 | 324 | Shares | Sole | 2026-01-07 | |
| No filing history on record for this holder in this stock. | ||||||